Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | KCNA3 | P22001 | 5/20 | 0.44 |
| ▸ | LIPE | Q05469 | 1/20 | 0.42 |
| ▸ | KCNA5 | P22460 | 4/20 | 0.42 |
| ▸ | KCNA1 | Q09470 | 2/20 | 0.42 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.41 |
| ▸ | KCNA2 | P16389 | 1/20 | 0.39 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28905201 | 0.79 | KCNA3 (0.49) | MAOBMAOAKCNA3PIN1 | |
| SCHEMBL29846180 | 0.79 | KCNA3 (0.49) | MAOBMAOAKCNA3PIN1 | |
| SCHEMBL31359523 | 0.78 | MAOB (0.45) | MAOBMAOAKCNA3LIPEKCNA5 | |
| SCHEMBL31359542 | 0.78 | MAOB (0.48) | MAOBMAOAKCNA3KCNA5KCNA1 | |
| SCHEMBL31359539 | 0.78 | MAOB (0.48) | MAOBMAOAKCNA3KCNA5KCNA1 | |
| SCHEMBL3372411 | 0.77 | MAOB (0.64) | MAOBMAOAKCNA3LIPE | |
| SCHEMBL31359519 | 0.77 | HPGD (0.55) | MAOBMAOAKCNA3 | |
| SCHEMBL4431406 | 0.76 | MRGPRX4 (0.50) | LIPE | |
| SCHEMBL4420078 | 0.75 | LIPE (0.47) | LIPE | |
| SCHEMBL31528156 | 0.73 | RAB9A (0.50) | MAOBLIPE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121586712-A | Novel compounds | 豪夫迈·罗氏有限公司 | 2026-02-27 | — | — | CN | disclosed |
| WO-2025026882-A1 | NOVEL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2025-02-06 | — | — | WO | disclosed |